Literature DB >> 28050153

Cancer referral and treatment activity 2010-2015: a population-based study from Vancouver Island.

P Savage1, C Holloway1, G Lindsay1, K Shubrook1, C Jones2, M Fung1, K Schaff1, H Anderson1, K Nystedt1, J Rauw1.   

Abstract

INTRODUCTION: The years since 2005 have seen major changes in cancer treatment and significant increases in the number of anticancer drugs available. However, there are relatively few published data to reflect how those changes are affecting the activity and workload of oncology services. To explore the effects of those changes, we reviewed the population-based cancer treatment activity on Vancouver Island for the period 2010-2015.
METHODS: Information about new patient referrals, radiation courses, new chemotherapy cycles commenced, total intravenous (IV) chemotherapy treatment visits, and pharmacy activity for oral anticancer drug prescriptions was obtained from BC Cancer Agency databases.
RESULTS: During the 5-year study period, the Vancouver Island population increased by 2.8% and the number of new referrals to the BC Cancer Agency increased by 17.7%. The overall number of radiation courses increased by 6.1%. In contrast, IV chemotherapy activity increased by 52.1% for new courses commenced and by 62% for total IV chemotherapy attendances. Oral anticancer drug prescriptions rose by 22.9% during the 5-year period.
CONCLUSIONS: Our study documents substantial recent increases in cancer therapy activity in terms of patient referrals and particularly IV chemotherapy and oral anticancer therapy. The data reported here could be of value in planning for future care provision.

Entities:  

Keywords:  Population data; chemotherapy; radiotherapy; workload

Year:  2016        PMID: 28050153      PMCID: PMC5176390          DOI: 10.3747/co.23.3306

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  9 in total

1.  A method of predicting workload and staffing level for radiotherapy treatment planning as plan complexity changes.

Authors:  O Holmberg; B McClean
Journal:  Clin Oncol (R Coll Radiol)       Date:  2003-09       Impact factor: 4.126

2.  Radiation oncology in a Canadian province: measures of workload and treatment complexity.

Authors:  B Mou; A L Cooke; K Suderman
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-11-04       Impact factor: 4.126

3.  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.

Authors:  Jonas A de Souza; Bonnie J Yap; Fay J Hlubocky; Kristen Wroblewski; Mark J Ratain; David Cella; Christopher K Daugherty
Journal:  Cancer       Date:  2014-06-20       Impact factor: 6.860

Review 4.  The state of cancer care in America, 2014: a report by the American Society of Clinical Oncology.

Authors: 
Journal:  J Oncol Pract       Date:  2014-03-10       Impact factor: 3.840

5.  Future supply and demand for oncologists : challenges to assuring access to oncology services.

Authors:  Clese Erikson; Edward Salsberg; Gaetano Forte; Suanna Bruinooge; Michael Goldstein
Journal:  J Oncol Pract       Date:  2007-03       Impact factor: 3.840

6.  Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Authors:  Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2009-04-29       Impact factor: 44.544

7.  American Society of Clinical Oncology guidance statement: the cost of cancer care.

Authors:  Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper
Journal:  J Clin Oncol       Date:  2009-07-06       Impact factor: 44.544

8.  Developing a performance data suite to facilitate lean improvement in a chemotherapy day unit.

Authors:  Senthil Lingaratnam; Danielle Murray; Amber Carle; Sue W Kirsa; Rebecca Paterson; Danny Rischin
Journal:  J Oncol Pract       Date:  2013-04-09       Impact factor: 3.840

9.  Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014.

Authors:  P Savage; S Mahmoud
Journal:  Br J Cancer       Date:  2015-03-17       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.